SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000929638-20-001140
Filing Date
2020-12-11
Accepted
2020-12-11 17:26:30
Documents
2
Group Members
JCP III SM AIV, L.P.JUGGERNAUT PARTNERS III GP, L.P.JUGGERNAUT PARTNERS III GP, LTD.METP HOLDINGS, LLCMETUCHEN THERAPEUTICS, LLC

Document Format Files

Seq Description Document Type Size
1 schedule13d.htm SC 13D 132580
2 exhibit99-1.htm EX-99.1 25733
  Complete submission text file 0000929638-20-001140.txt   159687
Mailing Address
Business Address
SHULMAN JOHN D (Filed by) CIK: 0001208886 (see all company filings)

Type: SC 13D

Mailing Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015
Business Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015 301-215-7440
Petros Pharmaceuticals, Inc. (Subject) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91895 | Film No.: 201384483
SIC: 2834 Pharmaceutical Preparations